This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
Genelux Corporation is a privately held, biopharmaceutical clinical stage company that was founded in 2001. The main focus of Genelux is oncolytic immunotherapy based on attenuated, genetically engineered oncolytic viruses as therapeutic agent. In 2013 Genelux obtained the San Diego Business Journal Innovation Award in the category of Medical Research.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:industry | |
| dbo:numberOfEmployees |
|
| dbo:numberOfLocations |
|
| dbo:product | |
| dbo:type | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink | |
| dbp:founder |
|
| dbp:homepage | |
| dbp:industry | |
| dbp:locationCity |
|
| dbp:locationCountry | |
| dbp:locations |
|
| dbp:name |
|
| dbp:numEmployees |
|
| dbp:products |
|
| dbp:type | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| skos:closeMatch | |
| prov:wasDerivedFrom | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |